Skip to main content

Table 1 Details of the immunohistochemical procedure used for each marker*

From: Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer

IHC procedure

Antigen Retrieval

Endogenous Peroxidase Blocking

Monoclonal Antibody

Secondary Antibody

Signal Amplification

Signal Detection

Kit used

p-Erk1/2

Preheated target retrieval solution (1×), water bath 97 ± 2°C, 30 min

Phosphate buffer containing hydrogen peroxide, 5 min

Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204); (1:100) (Cell Signalling, #4376), 1 h

Rabbit linker, 15 min

Polymer conjugated to horseradish peroxidase (HRP) and goat antirabbit and antimouse immunoglobulin, 30 min

 

EnVisionâ„¢ FLEX+ (Dako)

p-Akt

  

Phospho-Akt (Ser473); (1:25) (Cell Signalling, #3787), 1 h

    

Ki67

Preheated 0.01 M citrate buffer pH 6.0, microwave 800 W, 10 min

 

Clone MIB-1 (1:40) (Dako), 20 min

Biotinylated goat antimouse and antirabbit immunoglobulins, 15 min

Streptavidin conjugated to HRP, 15 min

DAB (chromogen) in hydrogen peroxide (substrate), 10 min

Realâ„¢ (Dako)

ER

  

Clone 6F11 (1:40) (Novocastra), 20 min

    

PgR

  

Clone 16 (1:100) (Novocastra), 20 min

    

HER2

Preheated 0.01 M citrate buffer, water bath 97 ± 2°C, 40 min

3% hydrogen peroxide, 5 min

Rabbit antihuman HER2 protein, 30 min

Polymer conjugated to HRP and goat antirabbit immunoglobulin, 30 min

 

HercepTestâ„¢ (Dako)

  1. *ER, oestrogen receptor: PgR, progesterone receptor; HER2, human epidermal growth factor receptor 2; HRP, horseradish peroxidase, DAB, 3,3'-diaminobenzidine.